NNS Clinical Research, LLC

Tucson, Arizona 85704

0 studies enrolling now · 2 studies all time

What they study most

Alzheimer's Disease

Studies at this site

• Multiple Dose Study of Aducanumab (BIIB037) (Recombinant, Fully Human Anti-Aβ IgG1 mAb) in Participants With Prodromal or Mild Alzheimer's Disease — Stopped early
• A Study to Evaluate the Impact of MABT5102A on Brain Amyloid Load and Related Biomarkers in Patients With Mild to Moderate Alzheimer's Disease — Completed